4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000950170-24-069885
Options or other derivatives
- Director acquired 45,664 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bronstein Ben Director | 2024-06-04 | Grant or award · Stock Option (Right to Buy) | +40,282 | 40,282 | D | ||
| Bronstein Ben Director | 2024-06-04 | Grant or award · Stock Option (Right to Buy) | +2,604 | 2,604 | D | ||
| Bronstein Ben Director | 2024-06-04 | Grant or award · Stock Option (Right to Buy) | +2,778 | 2,778 | D | ||
Loading xslF345X05/ownership.xml…